^○Noriko Toyama-Sorimachi (The Institute of Medical Science, The University of Tokyo (IMSUT))

^○Koji Hase^1,2, Nagai Motoyoshi³, Okawa Takuma^1,4, Kawamura Yuki I.⁴, Dohi Takeko^1,4 (1.Faculty of Pharmacy, Keio University, 2.International Research and Development Center for Mucosal Vaccines, the Institute of Medical Science, the University of Tokyo (IMSUT), 3.National Institute of Allergy and Infectious Diseases, National Institutes of Health, 4.Research Institute, National Center for Global Health and Medicine)

Rui Guo, Shaowen White, Jin-Hua Liang, Yuchen Zhang, Michael Lutchenkov, Zhixuan Li, Yin Wang, ^○Benjamin E. Gewurz (Division of Infectious Diseases, Brigham & Women's Hospital / Department of Microbiology, Harvard Medical School / Harvard Program in Virology / Center for Integrated Solutions to Infectious Diseases, Broad Institute of Harvard and MIT)

^○Ryo Ozuru, Ishii Kazunari, Fujiki Shotaro, Hiromatsu Kenji (Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University)

^○Yukihiro Hiramatsu¹, Nishida Takashi¹, Horiguchi Yasuhiko^1,2 (1.Department of Molecular Bacteriology, RIMD, Osaka University, Japan, 2.CiDER, Osaka University)